Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Honest Honest a Academic
Department of Obstetrics and Gynaecology, Birmingham Women's Hospital,
Birmingham B15 2TG, b Horten Centre, University of Zurich,
Bolleystrasse 40, CH-8091, Zurich, Switzerland, c NHS Centre for Reviews and
Dissemination, University of York, YorkYO10 5DD
Correspondence to: H Honest
h.honest{at}bham.ac.uk
Objective:
To determine the accuracy with which a
cervicovaginal fetal fibronectin test predicts spontaneous preterm
birth in women with or without symptoms of preterm labour.
What is already known on this topic
If spontaneous preterm birth can be predicted, effective therapeutic
strategies can be used to improve neonatal outcomes Though the cervicovaginal fetal fibronectin test has been proposed as a
predictive test, estimates of its accuracy are variable What this study adds
After a positive test result 17 symptomatic women at 31 weeks'
gestation would need to be treated with antenatal steroids to prevent
one case of respiratory distress syndrome
Design:
Systematic quantitative review of studies of
test accuracy.
Data sources:
Medline, Embase, PASCAL, Biosis,
Cochrane Library, Medion, National Research Register, SCISEARCH,
conference papers, manual searching of bibliographies of known primary
and review articles, and contact with experts and manufacturer.
Study selection:
Two reviewers independently selected
and extracted data on study characteristics, quality, and accuracy.
Data extraction:
Accuracy data were used to form 2×2
contingency tables with spontaneous preterm birth before 34 and 37 weeks' gestation and birth within 7-10 days of testing (for
symptomatic pregnant women) as reference standards. Data were pooled to
produce summary receiver operating characteristic curves and summary
likelihood ratios for positive and negative test results.
Data synthesis:
64 primary articles were identified,
consisting of 28 studies in asymptomatic women and 40 in symptomatic
women, with a total of 26 876 women. Among asymptomatic women the best summary likelihood ratio for positive results was 4.01 (95% confidence interval 2.93 to 5.49) for predicting birth before 34 weeks'
gestation, with corresponding summary likelihood ratio for negative
results of 0.78 (0.72 to 0.84). Among symptomatic women the best
summary likelihood ratio for positive results was 5.42 (4.36 to 6.74) for predicting birth within 7-10 days of testing, with corresponding ratio for negative results of 0.25 (0.20 to 0.31).
Conclusion:
Cervicovaginal fetal fibronectin test is
most accurate in predicting spontaneous preterm birth within 7-10 days of testing among women with symptoms of threatened preterm birth before
advanced cervical dilatation.
Spontaneous preterm birth is a major cause of neonatal morbidity and
mortality
The cervicovaginal fetal fibronectin test is most accurate in
predicting spontaneous preterm birth within 7-10 days of testing among
women with symptoms of threatened preterm birth before advanced
cervical dilatation
Read all Rapid Responses